医学
寻常性间质性肺炎
特发性肺纤维化
肺
纤维化
放射科
间质性肺病
内科学
比例危险模型
生存分析
射线照相术
肺炎
鉴别诊断
肺纤维化
病理
计算机断层摄影术
回顾性队列研究
试验预测值
肺纤维化
疾病严重程度
呼吸道疾病
观察研究
作者
David Baraghoshi,Devlin Thieke,Hiroto Hatabu,Gary Matthew Hunninghake,Jonathan Rose,Rachel K. Putman,Gunnar Guðmundsson,Vilmundur G. Gudnason,Joshua J. Solomon,Soonho Yoon,David A. Lynch,Stephen M. Humphries
标识
DOI:10.1093/ajrccm/aamag525
摘要
RATIONALE: Interstitial lung abnormalities (ILA) are common, but not all progress, highlighting the need for objective computed tomography (CT)-based biomarkers for risk stratification. OBJECTIVE: To determine whether deep learning-based classification of usual interstitial pneumonia (UIP) is associated with fibrosis progression and survival in individuals with ILA. METHODS: Baseline and follow-up CT scans from participants without clinically diagnosed interstitial lung disease in two large observational cohorts (COPDGene and AGES-Reykjavík) were analyzed using data-driven textural analysis (DTA) to quantify fibrosis and a deep learning-based classifier (MIL-UIP) to estimate UIP likelihood. Associations of baseline MIL-UIP with DTA trajectory and survival were evaluated using linear mixed and multivariable Cox models, respectively. MEASUREMENTS AND MAIN RESULTS: Baseline MIL-UIP > 0.5 was associated with relative annual DTA increases of 13.41% (95% CI: 8.10%, 18.99%; p < 0.001) and 14.10% (95% CI: 5.06%, 23.91%; p = 0.002) in COPDGene and AGES-Reykjavík, respectively. Each 0.1-point increase in MIL-UIP was associated with relative rates of DTA change that were 1.10 percentage points higher (95% CI: 0.45, 1.74; p < 0.001) in COPDGene and 1.30 percentage points higher (95% CI: 0.17, 2.45; p = 0.025) in AGES-Reykjavík. MIL-UIP > 0.5 was associated with higher mortality in COPDGene (HR 1.61; 95% CI: 1.08, 2.38; p = 0.018) and AGES-Reykjavík (HR 1.62; 95% CI: 1.01, 2.61; p = 0.046). Baseline DTA and MIL-UIP were highly associated with visual assessments of ILA, UIP, and fibrosis progression. CONCLUSION: Automated assessment of UIP-like CT features is associated with fibrosis progression and mortality in individuals with ILA, supporting its potential use for risk stratification and clinical trials enrichment.
科研通智能强力驱动
Strongly Powered by AbleSci AI